Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PROCEPT BioRobotics Corporation (PRCT)
USD19.27
-0.04 (-0.21%)
US NASDAQ Healthcare Medical - Devices
Address
900 Island Drive 94065
San Jose, CA, US
San Jose, CA, US
CEO
Larry L. Wood
Website
procept-biorobotics.com
IPO
2021-09-15
CIK 1588978 ISIN US74276L1052
Description
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD19.27
-0.04 (-0.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.85
Float Shares
54.53M
Free Float %
95.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.47% | +15.69% | +23.66% | +2.14% | -6.76% | -8.80% | -47.30% | -4.94% | -31.59% | -31.59% | -31.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
19.27
Low
30.00
+55.7%
Consensus
42.40
+120.0%
Median
35.00
+81.6%
High
62.00
+221.7%
DCF (Unlevered)
49.92
+159.1%
DCF (Levered)
80.27
+316.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
58% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
35.00
+81.6%
|
| Last Quarter | 3 |
33.00
+71.3%
|
| Last Year | 11 |
47.73
+147.7%
|
| All Time | 18 |
61.39
+218.6%
|
Quality scores
Altman Z-Score
5.91
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+37.2% ★ Q1'26: +20.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+1.7% Q1'26: -24.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-37.5% Q1'26: -49.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-33.7% Q1'26: -39.2% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-79.3% Q1'26: -84.9% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+6.6% Q1'26: +2.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.53× Q1'26: -0.42× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 8 EPS Ana. |
Dec 2027 9 Rev. Ana. 8 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
34.47M
est: 33.37M (+3.3%)
|
75.01M
est: 74.15M (+1.2%)
|
136.19M
est: 176.58M (-22.9%)
|
224.50M
est: 223.93M (+0.3%)
|
308.05M
est: 326.38M (-5.6%)
|
398.94M
394.93M – 404.55M
+22.2% YoY
|
491.78M
481.05M – 504.45M
+23.3% YoY
|
585.11M
583.70M – 586.53M
+19.0% YoY
|
670.71M
657.15M – 683.16M
+14.6% YoY
|
741.68M
726.68M – 755.44M
+10.6% YoY
|
| EBITDA |
-50.72M
est: -27.27M (-86.0%)
|
-79.13M
est: -60.59M (-30.6%)
|
-98.10M
est: 75.65M (-229.7%)
|
-82.00M
est: 95.94M (-185.5%)
|
-97.47M
est: 139.83M (-169.7%)
|
170.92M
169.20M – 173.32M
+22.2% YoY
|
210.69M
206.09M – 216.12M
+23.3% YoY
|
250.68M
250.07M – 251.29M
+19.0% YoY
|
287.35M
281.54M – 292.69M
+14.6% YoY
|
317.76M
311.33M – 323.65M
+10.6% YoY
|
| EBIT |
-54.04M
est: -27.61M (-95.8%)
|
-81.97M
est: -61.35M (-33.6%)
|
-101.90M
est: 76.42M (-233.3%)
|
-87.23M
est: 96.92M (-190.0%)
|
-103.86M
est: 141.26M (-173.5%)
|
172.66M
170.93M – 175.09M
+22.2% YoY
|
212.84M
208.20M – 218.32M
+23.3% YoY
|
253.24M
252.62M – 253.85M
+19.0% YoY
|
290.28M
284.41M – 295.67M
+14.6% YoY
|
321.00M
314.51M – 326.95M
+10.6% YoY
|
| Net Income |
-59.85M
est: -158.46M (+62.2%)
|
-87.15M
est: -98.00M (+11.1%)
|
-105.90M
est: -114.17M (+7.2%)
|
-91.41M
est: -97.84M (+6.6%)
|
-95.57M
est: -84.43M (-13.2%)
|
-86.66M
-91.61M – -79.40M
-2.6% YoY
|
-49.02M
-74.64M – -33.98M
+43.4% YoY
|
-34.31M
-67.05M – -19.34M
+30.0% YoY
|
-16.52M
-16.92M – -16.09M
+51.8% YoY
|
23.61M
22.99M – 24.18M
+242.9% YoY
|
| SGA |
51.04M
est: 55.51M (-8.1%)
|
88.83M
est: 123.37M (-28.0%)
|
131.77M
est: 181.47M (-27.4%)
|
171.42M
est: 230.13M (-25.5%)
|
228.81M
est: 335.42M (-31.8%)
|
409.99M
405.87M – 415.76M
+22.2% YoY
|
505.40M
494.37M – 518.42M
+23.3% YoY
|
601.32M
599.86M – 602.77M
+19.0% YoY
|
689.29M
675.35M – 702.08M
+14.6% YoY
|
762.22M
746.81M – 776.36M
+10.6% YoY
|
| EPS |
-1.37
est: -3.04 (+54.9%)
|
-1.96
est: -1.88 (-4.3%)
|
-2.24
est: -2.06 (-8.9%)
|
-1.75
est: -1.74 (-0.5%)
|
-1.72
est: -1.53 (-12.8%)
|
-1.53
-1.65 – -1.43
-0.3% YoY
|
-0.92
-1.34 – -0.61
+40.0% YoY
|
-0.63
-1.21 – -0.35
+30.9% YoY
|
-0.30
-0.30 – -0.29
+53.1% YoY
|
0.43
0.41 – 0.44
+242.9% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-30 | Piper Sandler | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-61.77M
OE per share TTM
-1.10
Owner's Yield
-4.13%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
25.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
60
Total invested
103.75M
Insider transactions (90d)
0
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANTAL ROHIT DESAI | 11.39M | 26.30% | 116.0K | 11.27M | 116.0K | 11.27M | HC, IN | — | 2021-09-27 | ↗ |
| 2 | CPMG, INC. | 11.22M | 25.90% | — | 11.22M | — | 11.22M | CO | — | 2021-09-27 | ↗ |
| 3 | R. KENT MCGAUGHY, JR. | 11.22M | 25.90% | — | 11.22M | — | 11.22M | HC, IN | — | 2021-09-27 | ↗ |
| 4 | WHITE TAILED PTARMIGAN, LP | 11.22M | 25.90% | — | 11.22M | — | 11.22M | PN | — | 2021-09-27 | ↗ |
| 5 | David C. Ott | 4.91M | 11.30% | — | 4.91M | — | 4.91M | IN | Delaware | 2022-02-14 | ↗ |
| 6 | O. Andreas Halvorsen | 4.91M | 11.30% | — | 4.91M | — | 4.91M | IN | Delaware | 2022-02-14 | ↗ |
| 7 | Rose S. Shabet | 4.91M | 11.30% | — | 4.91M | — | 4.91M | IN | Delaware | 2022-02-14 | ↗ |
| 8 | Viking Global Investors LP | 4.91M | 11.30% | — | 4.91M | — | 4.91M | PN | Delaware | 2022-02-14 | ↗ |
| 9 | Viking Global Opportunities GP LLC | 4.91M | 11.30% | — | 4.91M | — | 4.91M | OO | Delaware | 2022-02-14 | ↗ |
| 10 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 4.91M | 11.30% | — | 4.91M | — | 4.91M | PN | Delaware | 2022-02-14 | ↗ |
| 11 | Viking Global Opportunities Parent GP LLC | 4.91M | 11.30% | — | 4.91M | — | 4.91M | OO | Delaware | 2022-02-14 | ↗ |
| 12 | Viking Global Opportunities Portfolio GP LLC | 4.91M | 11.30% | — | 4.91M | — | 4.91M | OO | Delaware | 2022-02-14 | ↗ |
| 13 | Abigail P. Johnson | 3.87M | 8.91% | — | — | 3.87M | — | IN | United States of America | 2022-02-09 | ↗ |
| 14 | FMR LLC | 3.87M | 8.91% | 876.2K | — | 3.87M | — | HC | Delaware | 2022-02-09 | ↗ |
| 15 | 85-4328500 | 3.70M | 7.30% | 1.38M | — | 3.70M | — | IA | Maryland | 2024-02-14 | ↗ |
| 16 | (1) BlackRock, Inc. | 3.36M | 6.60% | 3.31M | — | 3.36M | — | HC | Delaware | 2024-01-26 | ↗ |
| 17 | DRAGSA 88 LLC | 400.0K | 0.90% | — | 400.0K | — | — | PN | Delaware | 2021-09-27 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
60
-213 vs prev Q
New positions
13
Closed positions
215
Increased
30
Reduced
10
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 194.0K +194.0K (+100.0%) | 6.11B +6.1B (+100.0%) | 0.35% +0.348 pp | 0.01% +0.009 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 2 | — | 119.5K +119.5K (+100.0%) | 3.76B +3.8B (+100.0%) | 0.21% +0.215 pp | 2.23% +2.234 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 3 | VANGUARD GROUP INC | 5.20M -3.1K (-0.1%) | 163.66M -22.1M (-11.9%) | 9.34% -0.053 pp | 0.00% 0.000 pp | USD41.88 -24.9% | 18 qtrs — |
| 4 | FMR LLC | 4.65M -3.4M (-42.1%) | 146.39M -140.4M (-49.0%) | 8.35% -6.144 pp | 0.01% -0.007 pp | USD40.50 -22.3% | 18 qtrs — |
| 5 | BLACKROCK, INC. | 4.35M +126.5K (+3.0%) | 136.76M -13.9M (-9.2%) | 7.80% +0.189 pp | 0.00% 0.000 pp | USD76.74 -59.0% | 6 qtrs — |
| 6 | ALLIANCEBERNSTEIN L.P. | 3.39M -34.4K (-1.0%) | 106.51M -15.5M (-12.7%) | 6.08% -0.093 pp | 0.03% -0.005 pp | USD42.83 -26.5% | 15 qtrs — |
| 7 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.27M +1.2M (+59.4%) | 102.92M +29.7M (+40.5%) | 5.87% +2.168 pp | 0.07% +0.020 pp | USD38.95 -19.2% | 14 qtrs — |
| 8 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 3.09M +2.0M (+183.3%) | 97.36M +58.4M (+149.7%) | 5.55% +3.583 pp | 0.11% +0.011 pp | USD36.01 -12.6% | 11 qtrs — |
| 9 | MACKENZIE FINANCIAL CORP | 1.57M +119.0K (+8.2%) | 49.51M -2.4M (-4.6%) | 2.82% +0.200 pp | 0.06% -0.004 pp | USD45.24 -30.5% | 6 qtrs — |
| 10 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.52M +155.6K (+11.4%) | 47.84M -879.2K (-1.8%) | 2.73% +0.267 pp | 0.07% +0.003 pp | USD46.74 -32.7% | 9 qtrs — |
| 11 | STATE STREET CORP | 1.49M +164.4K (+12.4%) | 46.84M -432.7K (-0.9%) | 2.67% +0.283 pp | 0.00% 0.000 pp | USD38.92 -19.2% | 17 qtrs — |
| 12 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 1.44M +3.1K (+0.2%) | 45.33M -6.0M (-11.7%) | 2.59% -0.008 pp | 0.46% +0.072 pp | USD44.23 -28.9% | 10 qtrs — |
| 13 | PROSIGHT MANAGEMENT, LP | 1.38M +1.3M (+1,692.4%) | 43.41M +40.7M (+1,480.0%) | 2.48% +2.338 pp | 8.97% +8.331 pp | USD31.70 -0.8% | 2 qtrs — |
| 14 | ARROWMARK COLORADO HOLDINGS LLC | 1.35M +221.5K (+19.6%) | 42.47M +2.2M (+5.5%) | 2.42% +0.387 pp | 0.93% +0.187 pp | USD40.55 -22.4% | 3 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.33M +21.3K (+1.6%) | 41.80M -4.9M (-10.4%) | 2.38% +0.026 pp | 0.00% 0.000 pp | USD43.57 -27.8% | 18 qtrs — |
| 16 | CHICAGO CAPITAL, LLC | 1.19M -377.9K (-24.1%) | 37.47M -18.5M (-33.1%) | 2.14% -0.692 pp | 0.93% -0.453 pp | USD46.42 -32.2% | 7 qtrs — |
| 17 | UBS GROUP AG | 1.05M +108.4K (+11.5%) | 33.13M -585.2K (-1.7%) | 1.89% +0.186 pp | 0.01% +0.000 pp | USD45.03 -30.1% | 18 qtrs — |
| 18 | BAILLIE GIFFORD & CO | 1.02M +157.1K (+18.3%) | 31.96M +1.3M (+4.3%) | 1.82% +0.274 pp | 0.03% +0.004 pp | USD53.76 -41.5% | 4 qtrs — |
| 19 | MORGAN STANLEY | 843.5K -183.0 (0.0%) | 26.54M -3.6M (-11.9%) | 1.51% -0.008 pp | 0.00% 0.000 pp | USD51.17 -38.5% | 18 qtrs — |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | 705.7K -169.4K (-19.4%) | 22.20M -9.0M (-28.9%) | 1.27% -0.312 pp | 0.00% -0.001 pp | USD45.57 -31.0% | 18 qtrs — |
| 21 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 700.0K +14.9K (+2.2%) | 22.02M -2.4M (-9.9%) | 1.26% +0.021 pp | 0.03% -0.006 pp | USD60.91 -48.4% | 7 qtrs — |
| 22 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 611.0K +221.0K (+56.7%) | 19.22M +5.3M (+38.1%) | 1.10% +0.393 pp | 1.80% +0.256 pp | USD35.66 -11.8% | 11 qtrs — |
| 23 | NORTHERN TRUST CORP | 553.1K +56.7K (+11.4%) | 17.40M -317.7K (-1.8%) | 0.99% +0.097 pp | 0.00% +0.000 pp | USD43.58 -27.8% | 17 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 517.7K +241.9K (+87.7%) | 16.29M +6.4M (+65.4%) | 0.93% +0.432 pp | 0.00% +0.001 pp | USD49.48 -36.4% | 18 qtrs — |
| 25 | BELLEVUE GROUP AG | 515.4K +52.0K (+11.2%) | 16.22M -323.5K (-2.0%) | 0.92% +0.089 pp | 0.31% -0.036 pp | USD37.95 -17.1% | 18 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 462.4K +2.2K (+0.5%) | 14.55M -1.9M (-11.4%) | 0.83% 0.000 pp | 0.00% 0.000 pp | USD45.01 -30.1% | 17 qtrs — |
| 27 | BANK OF AMERICA CORP /DE/ | 431.2K +27.0K (+6.7%) | 13.57M -861.8K (-6.0%) | 0.77% +0.045 pp | 0.00% +0.000 pp | USD55.67 -43.5% | 18 qtrs — |
| 28 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 416.2K +33.2K (+8.7%) | 13.10M -574.9K (-4.2%) | 0.75% +0.056 pp | 0.04% +0.001 pp | USD65.75 -52.2% | 6 qtrs — |
| 29 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 389.3K +389.3K (+100.0%) | 12.25M +12.2M (+100.0%) | 0.70% +0.699 pp | 0.02% +0.019 pp | USD31.46 +0.0% | 4 qtrs — |
| 30 | MILLENNIUM MANAGEMENT LLC | 383.1K +278.1K (+264.7%) | 12.05M +8.3M (+221.5%) | 0.69% +0.498 pp | 0.01% +0.004 pp | USD41.29 -23.8% | 8 qtrs — |
| 31 | C WORLDWIDE GROUP HOLDING A/S | 375.0K +225.0K (+150.0%) | 11.80M +6.4M (+120.4%) | 0.67% +0.402 pp | 0.21% +0.123 pp | USD33.15 -5.1% | 2 qtrs — |
| 32 | JOHNSON & JOHNSON | 357.9K +— (+0.0%) | 11.26M -1.5M (-11.9%) | 0.64% -0.003 pp | 2.03% -0.493 pp | USD38.15 -17.5% | 18 qtrs — |
| 33 | JANUS HENDERSON GROUP PLC | 340.8K +315.1K (+1,222.3%) | 10.72M +9.8M (+1,066.0%) | 0.61% +0.565 pp | 0.00% +0.004 pp | USD32.18 -2.2% | 11 qtrs — |
| 34 | NEW YORK STATE COMMON RETIREMENT FUND | 331.2K +63.7K (+23.8%) | 10.42M +873.5K (+9.2%) | 0.59% +0.112 pp | 0.01% +0.002 pp | USD49.91 -37.0% | 16 qtrs — |
| 35 | EAGLE HEALTH INVESTMENTS LP | 308.4K +— (+0.0%) | 9.70M -1.3M (-11.9%) | 0.55% -0.003 pp | 2.13% -0.758 pp | USD35.84 -12.2% | 12 qtrs — |
| 36 | NUVEEN, LLC | 282.3K -397.7K (-58.5%) | 8.88M -15.4M (-63.4%) | 0.51% -0.720 pp | 0.00% -0.004 pp | USD49.73 -36.7% | 4 qtrs — |
| 37 | FIERA CAPITAL CORP | 276.5K +63.2K (+29.6%) | 8.70M +1.1M (+14.3%) | 0.50% +0.111 pp | 0.03% +0.003 pp | USD69.10 -54.5% | 5 qtrs — |
| 38 | TWO SIGMA INVESTMENTS, LP | 266.5K +122.3K (+84.8%) | 8.38M +3.2M (+62.9%) | 0.48% +0.218 pp | 0.01% +0.004 pp | USD47.90 -34.3% | 9 qtrs — |
| 39 | GRANITE INVESTMENT PARTNERS, LLC | 265.6K +190.8K (+254.8%) | 8.36M +5.7M (+212.8%) | 0.48% +0.342 pp | 0.50% +0.344 pp | USD38.83 -19.0% | 3 qtrs — |
| 40 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 263.2K -22.8K (-8.0%) | 8.28M -1.9M (-18.9%) | 0.47% -0.044 pp | 0.00% -0.001 pp | USD34.21 -8.0% | 18 qtrs — |
| 41 | PORTOLAN CAPITAL MANAGEMENT, LLC | 255.1K +255.1K (+100.0%) | 8.03M +8.0M (+100.0%) | 0.46% +0.458 pp | 0.43% +0.430 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 42 | OSTERWEIS CAPITAL MANAGEMENT INC | 237.5K +3.8K (+1.6%) | 7.47M -869.1K (-10.4%) | 0.43% +0.005 pp | 0.32% -0.060 pp | USD49.72 -36.7% | 8 qtrs — |
| 43 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 237.2K +237.2K (+100.0%) | 7.46M +7.5M (+100.0%) | 0.43% +0.426 pp | 0.06% +0.059 pp | USD31.46 +0.0% | 3 qtrs — |
| 44 | FRONTIER CAPITAL MANAGEMENT CO LLC | 234.2K +128.7K (+122.0%) | 7.37M +3.6M (+95.7%) | 0.42% +0.230 pp | 0.08% +0.044 pp | USD48.54 -35.2% | 5 qtrs — |
| 45 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 228.2K +220.1K (+2,727.2%) | 7.18M +6.9M (+2,392.1%) | 0.41% +0.395 pp | 0.01% +0.012 pp | USD31.61 -0.5% | 2 qtrs — |
| 46 | WASATCH ADVISORS LP | 222.4K +65.9K (+42.1%) | 7.00M +1.4M (+25.3%) | 0.40% +0.117 pp | 0.04% +0.012 pp | USD53.71 -41.4% | 5 qtrs — |
| 47 | SEGALL BRYANT & HAMILL, LLC | 218.3K +9.8K (+4.7%) | 6.87M -573.7K (-7.7%) | 0.39% +0.016 pp | 0.09% -0.006 pp | USD70.72 -55.5% | 6 qtrs — |
| 48 | MARSHALL WACE, LLP | 217.4K -164.1K (-43.0%) | 6.84M -6.8M (-49.8%) | 0.39% -0.298 pp | 0.01% -0.008 pp | USD35.94 -12.5% | 7 qtrs — |
| 49 | BLAIR WILLIAM & CO/IL | 210.3K -456.2K (-68.4%) | 6.61M -17.2M (-72.2%) | 0.38% -0.825 pp | 0.02% -0.046 pp | USD45.71 -31.2% | 8 qtrs — |
| 50 | WERBA RUBIN PAPIER WEALTH MANAGEMENT | 210.0K +— (+0.0%) | 6.61M -888.3K (-11.9%) | 0.38% -0.002 pp | 1.79% +0.580 pp | USD58.26 -46.0% | 4 qtrs — |
| 51 | BNP PARIBAS ARBITRAGE, SNC | 208.0K +116.0K (+126.1%) | 6.54M +3.3M (+99.3%) | 0.37% +0.207 pp | 0.00% +0.001 pp | USD42.75 -26.4% | 5 qtrs — |
| 52 | SQUAREPOINT OPS LLC | 191.6K +191.6K (+100.0%) | 6.03M +6.0M (+100.0%) | 0.34% +0.344 pp | 0.01% +0.006 pp | USD31.46 +0.0% | 13 qtrs — |
| 53 | PEREGRINE CAPITAL MANAGEMENT LLC | 185.8K -2.4K (-1.3%) | 5.85M -871.5K (-13.0%) | 0.33% -0.006 pp | 0.18% -0.023 pp | USD35.69 -11.9% | 2 qtrs — |
| 54 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 171.0K +171.0K (+100.0%) | 5.38M +5.4M (+100.0%) | 0.31% +0.307 pp | 0.04% +0.037 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 55 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 174.7K +71.8K (+69.8%) | 5.37M +1.7M (+46.3%) | 0.31% +0.128 pp | 0.00% +0.001 pp | USD48.46 -35.1% | 15 qtrs — |
| 56 | TD ASSET MANAGEMENT INC | 163.4K +19.4K (+13.5%) | 5.14M +1.4K (+0.0%) | 0.29% +0.034 pp | 0.00% +0.000 pp | USD45.17 -30.4% | 18 qtrs — |
| 57 | FEDERATED HERMES, INC. | 150.0K -230.8K (-60.6%) | 4.72M -8.9M (-65.3%) | 0.27% -0.418 pp | 0.01% -0.016 pp | USD73.88 -57.4% | 8 qtrs — |
| 58 | BANK OF NEW YORK MELLON CORP | 149.1K -40.7K (-21.4%) | 4.69M -2.1M (-30.7%) | 0.27% -0.075 pp | 0.00% -0.001 pp | USD45.53 -30.9% | 17 qtrs — |
| 59 | TREXQUANT INVESTMENT LP | 148.0K +148.0K (+100.0%) | 4.66M +4.7M (+100.0%) | 0.27% +0.266 pp | 0.04% +0.042 pp | USD31.46 +0.0% | 4 qtrs — |
| 60 | CITIGROUP INC | 144.6K +15.7K (+12.2%) | 4.55M -50.8K (-1.1%) | 0.26% +0.027 pp | 0.00% +0.000 pp | USD50.63 -37.9% | 17 qtrs — |
| 61 | UBS ASSET MANAGEMENT AMERICAS INC | 135.8K +4.4K (+3.3%) | 4.27M -418.8K (-8.9%) | 0.24% +0.007 pp | 0.00% 0.000 pp | USD56.27 -44.1% | 13 qtrs — |
| 62 | PINNACLE ASSOCIATES LTD | 123.2K +123.2K (+100.0%) | 3.88M +3.9M (+100.0%) | 0.22% +0.221 pp | 0.05% +0.050 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 63 | FRANK, RIMERMAN ADVISORS LLC | 122.5K +93.0 (+0.1%) | 3.85M -514.8K (-11.8%) | 0.22% -0.001 pp | 0.24% -0.036 pp | USD32.71 -3.8% | 15 qtrs — |
| 64 | DAFNA CAPITAL MANAGEMENT LLC | 120.0K +120.0K (+100.0%) | 3.78M +3.8M (+100.0%) | 0.22% +0.215 pp | 0.88% +0.877 pp | USD31.46 +0.0% | 3 qtrs — |
| 65 | TRANSATLANTIQUE PRIVATE WEALTH LLC | 118.4K +— (+0.0%) | 3.73M -501.0K (-11.9%) | 0.21% -0.001 pp | 1.17% -0.214 pp | USD61.87 -49.2% | 7 qtrs — |
| 66 | RENAISSANCE TECHNOLOGIES LLC | 117.5K +117.5K (+100.0%) | 3.70M +3.7M (+100.0%) | 0.21% +0.211 pp | 0.01% +0.006 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 67 | XTX TOPCO LTD | 112.7K +112.7K (+100.0%) | 3.55M +3.5M (+100.0%) | 0.20% +0.202 pp | 0.09% +0.093 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 68 | SWISS NATIONAL BANK | 109.7K +2.5K (+2.3%) | 3.45M -374.8K (-9.8%) | 0.20% +0.004 pp | 0.00% 0.000 pp | USD38.61 -18.5% | 15 qtrs — |
| 69 | EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC | 100.9K +25.9K (+34.5%) | 3.17M +497.3K (+18.6%) | 0.18% +0.046 pp | 3.69% +0.768 pp | USD40.50 -22.3% | 12 qtrs — |
| 70 | ROBOCAP ASSET MANAGEMENT LTD | 99.8K -39.0K (-28.1%) | 3.14M -1.8M (-36.6%) | 0.18% -0.071 pp | 2.80% -0.354 pp | USD40.24 -21.8% | 12 qtrs — |
| 71 | DNB ASSET MANAGEMENT AS | 99.6K +67.8K (+213.9%) | 3.13M +2.0M (+176.7%) | 0.18% +0.122 pp | 0.01% +0.007 pp | USD32.81 -4.1% | 2 qtrs — |
| 72 | MITSUBISHI UFJ TRUST & BANKING CORP | 97.9K -3.6K (-3.5%) | 3.08M -542.3K (-15.0%) | 0.18% -0.007 pp | 0.01% -0.001 pp | USD57.60 -45.4% | 3 qtrs — |
| 73 | BARCLAYS PLC | 96.3K +18.4K (+23.6%) | 3.03M -3.2M (-51.5%) | 0.17% +0.032 pp | 0.00% -0.001 pp | USD59.70 -47.3% | 16 qtrs — |
| 74 | WELLS FARGO & COMPANY/MN | 93.9K +24.2K (+34.7%) | 2.95M +466.8K (+18.8%) | 0.17% +0.043 pp | 0.00% +0.000 pp | USD44.26 -28.9% | 17 qtrs — |
| 75 | CITADEL ADVISORS LLC | 91.1K +54.3K (+147.8%) | 2.86M +1.6M (+118.4%) | 0.16% +0.097 pp | 0.00% +0.000 pp | USD35.88 -12.3% | 18 qtrs — |
| 76 | ENVESTNET ASSET MANAGEMENT INC | 88.1K +60.0K (+214.3%) | 2.77M +1.8M (+177.0%) | 0.16% +0.108 pp | 0.00% +0.001 pp | USD45.55 -30.9% | 7 qtrs — |
| 77 | ENGINEERS GATE MANAGER LP | 87.1K +80.0K (+1,127.4%) | 2.74M +2.5M (+981.9%) | 0.16% +0.144 pp | 0.03% +0.030 pp | USD31.80 -1.1% | 6 qtrs — |
| 78 | NORGES BANK | 86.2K +86.2K (+100.0%) | 2.71M +2.7M (+100.0%) | 0.15% +0.155 pp | 0.00% +0.000 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 79 | SG AMERICAS SECURITIES, LLC | 84.3K +49.5K (+142.0%) | 2.65M +1.4M (+113.4%) | 0.15% +0.088 pp | 0.00% -0.001 pp | USD33.74 -6.8% | 13 qtrs — |
| 80 | STATE OF WISCONSIN INVESTMENT BOARD | 83.7K +19.1K (+29.6%) | 2.63M +328.5K (+14.3%) | 0.15% +0.034 pp | 0.01% +0.001 pp | USD54.46 -42.2% | 7 qtrs — |
| 81 | TAYLOR FRIGON CAPITAL MANAGEMENT LLC | 72.0K -815.0 (-1.1%) | 2.27M -333.7K (-12.8%) | 0.13% -0.002 pp | 1.15% -0.146 pp | USD37.91 -17.0% | 14 qtrs — |
| 82 | SEI INVESTMENTS CO | 71.0K +1.9K (+2.8%) | 2.23M -231.8K (-9.4%) | 0.13% +0.003 pp | 0.00% 0.000 pp | USD56.99 -44.8% | 15 qtrs — |
| 83 | HRT FINANCIAL LP | 69.9K +69.9K (+100.0%) | 2.20M +2.2M (+100.0%) | 0.13% +0.125 pp | 0.01% +0.007 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 84 | ABRDN PLC | 69.1K +20.0K (+40.8%) | 2.18M +421.4K (+24.0%) | 0.12% +0.036 pp | 0.00% +0.001 pp | USD38.75 -18.8% | 13 qtrs — |
| 85 | SCHONFELD STRATEGIC ADVISORS LLC | 68.0K +14.5K (+27.1%) | 2.14M +230.3K (+12.1%) | 0.12% +0.026 pp | 0.01% -0.001 pp | USD42.90 -26.7% | 7 qtrs — |
| 86 | RHUMBLINE ADVISERS | 65.5K -10.0K (-13.3%) | 2.06M -634.5K (-23.6%) | 0.12% -0.019 pp | 0.00% -0.001 pp | USD43.78 -28.1% | 16 qtrs — |
| 87 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 64.2K -8.7K (-11.9%) | 2.02M -578.6K (-22.2%) | 0.12% -0.016 pp | 0.00% -0.001 pp | USD44.94 -30.0% | 16 qtrs — |
| 88 | HOLOCENE ADVISORS, LP | 62.7K +12.3K (+24.5%) | 1.97M +174.8K (+9.7%) | 0.11% +0.022 pp | 0.00% +0.000 pp | USD34.86 -9.8% | 2 qtrs — |
| 89 | B. METZLER SEEL. SOHN & CO. AG | 59.2K +59.2K (+100.0%) | 1.86M +1.9M (+100.0%) | 0.11% +0.106 pp | 0.02% +0.016 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 90 | ALGERT GLOBAL LLC | 57.9K +25.8K (+80.6%) | 1.82M +677.0K (+59.2%) | 0.10% +0.046 pp | 0.03% +0.009 pp | USD47.52 -33.8% | 7 qtrs — |
| 91 | LANE GENERATIONAL LLC | 56.8K +56.8K (+100.0%) | 1.79M +1.8M (+100.0%) | 0.10% +0.102 pp | 1.62% +1.620 pp | USD31.46 +0.0% | 1 qtrs NEW |
| 92 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 52.2K +3.0 (+0.0%) | 1.64M -220.9K (-11.8%) | 0.09% -0.001 pp | 0.00% 0.000 pp | USD37.43 -15.9% | 17 qtrs — |
| 93 | LEGAL & GENERAL GROUP PLC | 51.5K -6.7K (-11.5%) | 1.62M -457.2K (-22.0%) | 0.09% -0.013 pp | 0.00% 0.000 pp | USD42.59 -26.1% | 17 qtrs — |
| 94 | GENERALI INVESTMENTS TOWARZYSTWO FUNDUSZY INWESTYCYJNYCH | 50.0K +24.0K (+92.3%) | 1.57M +645.1K (+69.5%) | 0.09% +0.043 pp | 0.77% +0.274 pp | USD42.20 -25.5% | 4 qtrs — |
| 95 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 48.5K -79.9K (-62.2%) | 1.53M -3.1M (-66.7%) | 0.09% -0.145 pp | 0.00% 0.000 pp | USD52.94 -40.6% | 11 qtrs — |
| 96 | DEUTSCHE BANK AG\ | 47.8K +4.2K (+9.7%) | 1.50M -51.6K (-3.3%) | 0.09% +0.007 pp | 0.00% +0.000 pp | USD70.58 -55.4% | 17 qtrs — |
| 97 | JPMORGAN CHASE & CO | 47.1K -560.8K (-92.2%) | 1.48M -20.2M (-93.2%) | 0.08% -1.012 pp | 0.00% -0.001 pp | USD59.15 -46.8% | 17 qtrs — |
| 98 | CREATIVE PLANNING | 46.8K +21.5K (+85.4%) | 1.47M +571.0K (+63.4%) | 0.08% +0.038 pp | 0.00% +0.000 pp | USD40.57 -22.5% | 7 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 109 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Health Care Equipment ETF XHE | 1.12% | 1.70M | 0.35% |
| 2 | Global X HealthTech ETF HEAL | 1.02% | 305.9K | 0.50% |
| 3 | ALPS Disruptive Technologies ETF DTEC | 0.70% | 493.9K | 0.50% |
| 4 | Federated Hermes MDT Small Cap Core ETF FSCC | 0.52% | 855.0K | 0.51% |
| 5 | Truth Social American Next Frontiers ETF TSNF | 0.49% | 50.5K | 0.65% |
| 6 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTG.L | 0.36% | 91.7K | 0.50% |
| 7 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTZ.L | 0.36% | 562.8K | 0.50% |
| 8 | Fidelity Disruptive Medicine ETF FMED | 0.27% | 124.6K | 0.50% |
| 9 | Global X - Robotics & Artificial Intelligence ETF BOTZ | 0.26% | 8.84M | 0.68% |
| 10 | iShares U.S. Medical Devices ETF IHI | 0.18% | 5.56M | 0.38% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.13
Bullish
Ratio by volume
3.00
Bullish
Buys
17
Sells
8
Shares acquired
833.9K
Shares disposed
23.2K
Cash buys
7.00
Cash sales
8.00
Net activity
+810,710
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Templin Barry L | Officer | — | — | Common Stock | 0 | 0.00 | — | 69,311 | D | ↗ |
| 2026-04-16 | Sharma Pooja | Officer | — | — | Stock Option (Right to Buy) | 29,615 | 25.35 | 750.7K | 0 | D | ↗ |
| 2026-03-19 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 3,031 | 25.82 | 78.3K | 107,686 | D | ↗ |
| 2026-03-17 | Waters Kevin | Officer | S-Sale | D | Common Stock | 706 | 28.15 | 19.9K | 151,558 | D | ↗ |
| 2026-03-17 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 304 | 28.15 | 8.6K | 110,717 | D | ↗ |
| 2026-03-10 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 3,098 | 25.60 | 79.3K | 111,166 | D | ↗ |
| 2026-03-09 | Desai Antal Rohit | Director | P-Purchase | A | Common Stock | 1,300 | 25.42 | 33.0K | 426,262 | I | ↗ |
| 2026-03-06 | Waters Kevin | Officer | S-Sale | D | Common Stock | 6,721 | 23.70 | 159.3K | 152,264 | D | ↗ |
| 2026-03-06 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 6,892 | 23.70 | 163.4K | 114,264 | D | ↗ |
| 2026-03-06 | Desai Antal Rohit | Director | P-Purchase | A | Common Stock | 106,554 | 23.33 | 2.49M | 273,800 | I | ↗ |
| 2026-03-05 | Wood Larry L | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 103,653 | 25.35 | 2.63M | 103,653 | D | ↗ |
| 2026-03-05 | Waters Kevin | Officer | A-Award | A | Common Stock | 47,462 | 0.00 | — | 158,985 | D | ↗ |
| 2026-03-05 | PUCKETT DAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-05 | Nouri Alaleh | Officer | A-Award | A | Stock Option (Right to Buy) | 29,615 | 25.35 | 750.7K | 29,615 | D | ↗ |
| 2026-03-05 | Desai Antal Rohit | Director | P-Purchase | A | Common Stock | 24,748 | 26.41 | 653.5K | 167,246 | I | ↗ |
| 2026-02-19 | Waters Kevin | Officer | A-Award | A | Common Stock | 3,532 | 0.00 | — | 111,523 | D | ↗ |
| 2026-02-19 | Nouri Alaleh | Officer | A-Award | A | Common Stock | 4,872 | 0.00 | — | 77,345 | D | ↗ |
| 2025-09-02 | Wood Larry L | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 319,618 | 39.57 | 12.65M | 319,618 | D | ↗ |
| 2025-08-14 | Nouri Alaleh | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 4.52 | 49.7K | 54,452 | D | ↗ |
| 2025-08-14 | Desai Antal Rohit | Director | M-Exempt | A | Common Stock | 26,749 | 1.33 | 35.6K | 35,152 | D | ↗ |
| 2025-08-13 | MOLL FREDERIC H | Director | P-Purchase | A | Common Stock | 20,000 | 39.26 | 785.1K | 863,159 | D | ↗ |
| 2025-06-12 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 19,951 | 61.28 | 1.22M | 19,412 | I | ↗ |
| 2025-06-11 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 7,788 | 62.59 | 487.5K | 56,575 | I | ↗ |
| 2025-06-10 | Wood Larry L | Director | A-Award | A | Common Stock | 1,538 | 0.00 | — | 5,968 | D | ↗ |
| 2025-06-10 | Sandoval Elisabeth | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-10 | PRESCOTT THOMAS M | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-10 | MOLL FREDERIC H | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-10 | Harris Taylor C. | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-10 | Garrett Mary | Director | A-Award | A | Common Stock | 1,538 | 0.00 | — | 14,385 | D | ↗ |
| 2025-06-10 | Dodrill Amy M. | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-10 | Desai Antal Rohit | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 64.23 | 178.0K | 2,771 | D | ↗ |
| 2025-06-06 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 5,904 | 64.64 | 381.6K | 64,933 | D | ↗ |
| 2025-06-05 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 700 | 61.85 | 43.3K | 113,663 | I | ↗ |
| 2025-06-04 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 16,400 | 60.82 | 997.5K | 122,963 | I | ↗ |
| 2025-06-03 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 9,880 | 60.23 | 595.1K | 152,483 | I | ↗ |
| 2025-05-09 | Zadno Reza | Director / Officer | M-Exempt | A | Common Stock | 13,759 | 7.27 | 100.0K | 186,829 | D | ↗ |
| 2025-03-18 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 5,475 | 57.06 | 312.4K | 173,070 | D | ↗ |
| 2025-03-18 | Waters Kevin | Officer | S-Sale | D | Common Stock | 733 | 57.06 | 41.8K | 107,991 | D | ↗ |
| 2025-03-18 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 247 | 57.06 | 14.1K | 63,133 | D | ↗ |
| 2025-03-18 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 316 | 57.06 | 18.0K | 61,473 | D | ↗ |
| 2025-03-06 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 15,916 | 61.31 | 975.8K | 178,545 | D | ↗ |
| 2025-03-06 | Waters Kevin | Officer | S-Sale | D | Common Stock | 3,662 | 61.31 | 224.5K | 108,724 | D | ↗ |
| 2025-03-06 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 3,588 | 61.31 | 220.0K | 63,380 | D | ↗ |
| 2025-03-06 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 3,641 | 61.31 | 223.2K | 61,789 | D | ↗ |
| 2025-03-03 | Zadno Reza | Director / Officer | A-Award | A | Common Stock | 41,699 | 0.00 | — | 194,461 | D | ↗ |
| 2025-03-03 | Waters Kevin | Officer | A-Award | A | Common Stock | 16,290 | 0.00 | — | 112,386 | D | ↗ |
| 2025-03-03 | Shiblaq Hisham | Officer | A-Award | A | Common Stock | 11,107 | 0.00 | — | 66,968 | D | ↗ |
| 2025-03-03 | Nouri Alaleh | Officer | A-Award | A | Common Stock | 12,958 | 0.00 | — | 65,430 | D | ↗ |
| 2025-02-10 | MOLL FREDERIC H | Director | M-Exempt | D | Stock Option (Right to Buy) | 5,263 | 0.86 | 4.5K | 0 | D | ↗ |
| 2024-12-04 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 2,235 | 99.04 | 221.4K | 152,762 | D | ↗ |
| 2024-12-04 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 4,162 | 34.99 | 145.6K | 68,472 | D | ↗ |
| 2024-11-27 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 18,144 | 97.25 | 1.76M | 187,461 | D | ↗ |
| 2024-11-20 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 10,111 | 92.12 | 931.4K | 221,914 | D | ↗ |
| 2024-11-13 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 2,000 | 93.64 | 187.3K | 245,936 | D | ↗ |
| 2024-11-07 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 6,992 | 94.42 | 660.2K | 191,371 | I | ↗ |
| 2024-11-06 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 9,403 | 95.68 | 899.6K | 221,960 | I | ↗ |
| 2024-11-05 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 7,566 | 95.38 | 721.7K | 256,797 | I | ↗ |
| 2024-10-30 | Zadno Reza | Director / Officer | M-Exempt | A | Common Stock | 288,461 | 4.37 | 1.26M | 546,906 | D | ↗ |
| 2024-10-15 | Waters Kevin | Officer | M-Exempt | A | Common Stock | 25,000 | 4.56 | 114.0K | 121,096 | D | ↗ |
| 2024-09-16 | Waters Kevin | Officer | S-Sale | D | Common Stock | 17,977 | 82.69 | 1.49M | 96,496 | — | ↗ |
| 2024-09-12 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 28,689 | 80.65 | 2.31M | 197,453 | — | ↗ |
| 2024-09-11 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 20,732 | 78.12 | 1.62M | 246,502 | — | ↗ |
| 2024-09-10 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 17,810 | 76.60 | 1.36M | 281,018 | — | ↗ |
| 2024-09-05 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 12,405 | 76.33 | 946.8K | 318,418 | — | ↗ |
| 2024-09-04 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 200 | 76.41 | 15.3K | 6,543 | — | ↗ |
| 2024-09-03 | Desai Antal Rohit | Director | S-Sale | D | Common Stock | 19,725 | 76.32 | 1.51M | 28,692 | — | ↗ |
| 2024-07-31 | Zadno Reza | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 23,484 | 4.37 | 102.6K | 1,249,609 | — | ↗ |
| 2024-07-18 | PRESCOTT THOMAS M | Director | A-Award | A | Stock Option (Right to Buy) | 4,115 | 66.75 | 274.7K | 4,115 | — | ↗ |
| 2024-06-17 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 8,952 | 62.04 | 555.4K | 53,520 | — | ↗ |
| 2024-06-10 | Shiblaq Hisham | Officer | M-Exempt | D | Stock Option (Right to Buy) | 26,046 | 4.56 | 118.8K | 119,450 | — | ↗ |
| 2024-06-04 | Wood Larry L | Director | A-Award | A | Common Stock | 1,376 | 0.00 | — | 4,430 | — | ↗ |
| 2024-06-04 | Sandoval Elisabeth | Director | A-Award | A | Common Stock | 1,376 | 0.00 | — | 11,023 | — | ↗ |
| 2024-06-04 | MOLL FREDERIC H | Director | A-Award | A | Common Stock | 1,376 | 0.00 | — | 809,609 | — | ↗ |
| 2024-06-04 | Krummel Thomas M | Director | A-Award | A | Stock Option (Right to Buy) | 2,526 | 67.29 | 170.0K | 2,526 | — | ↗ |
| 2024-06-04 | Harris Taylor C. | Director | M-Exempt | D | Stock Option (Right to Buy) | 81,550 | 5.18 | 422.4K | 13,923 | — | ↗ |
| 2024-06-04 | Garrett Mary | Director | A-Award | A | Stock Option (Right to Buy) | 2,526 | 67.29 | 170.0K | 2,526 | — | ↗ |
| 2024-06-04 | Dodrill Amy M. | Director | A-Award | A | Common Stock | 1,376 | 0.00 | — | 6,088 | — | ↗ |
| 2024-06-04 | Desai Antal Rohit | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 2,526 | 67.29 | 170.0K | 2,526 | — | ↗ |
| 2024-05-20 | Desai Antal Rohit | Director / 10% Owner | J-Other | D | Common Stock | 1,949,104 | 0.00 | — | 711,547 | — | ↗ |
| 2024-05-03 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 13,935 | 62.79 | 875.0K | 77,042 | — | ↗ |
| 2024-05-03 | McGaughy R Kent Jr | 10% Owner | J-Other | D | Common Stock | 1,785,127 | 0.00 | — | 2,823,681 | — | ↗ |
| 2024-05-03 | Desai Antal Rohit | Director / 10% Owner | J-Other | D | Common Stock | 1,785,127 | 0.00 | — | 2,823,681 | — | ↗ |
| 2024-05-01 | Krummel Thomas M | Director | S-Sale | D | Common Stock | 20,000 | 60.00 | 1.20M | 45,631 | — | ↗ |
| 2024-04-18 | Wood Larry L | Director | A-Award | A | Stock Option (Right to Buy) | 5,284 | 51.08 | 269.9K | 5,284 | — | ↗ |
| 2024-03-18 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 5,391 | 48.83 | 263.2K | 241,319 | — | ↗ |
| 2024-03-18 | Waters Kevin | Officer | S-Sale | D | Common Stock | 1,024 | 48.83 | 50.0K | 102,149 | — | ↗ |
| 2024-03-18 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 244 | 48.83 | 11.9K | 55,860 | — | ↗ |
| 2024-03-18 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 441 | 48.83 | 21.5K | 62,472 | — | ↗ |
| 2024-03-15 | Waters Kevin | Officer | M-Exempt | A | Common Stock | 17,747 | 4.56 | 80.9K | 103,173 | — | ↗ |
| 2024-03-06 | Zadno Reza | Director / Officer | A-Award | A | Common Stock | 54,933 | 0.00 | — | 255,889 | — | ↗ |
| 2024-03-06 | Waters Kevin | Officer | S-Sale | D | Common Stock | 3,435 | 46.67 | 160.3K | 49,416 | — | ↗ |
| 2024-03-06 | Shiblaq Hisham | Officer | A-Award | A | Stock Option (Right to Buy) | 23,038 | 47.17 | 1.09M | 23,038 | — | ↗ |
| 2024-03-06 | Nouri Alaleh | Officer | A-Award | A | Stock Option (Right to Buy) | 15,949 | 47.17 | 752.3K | 15,949 | — | ↗ |
| 2024-03-04 | Krummel Thomas M | Director | S-Sale | D | Common Stock | 11,762 | 48.21 | 567.1K | 73,869 | — | ↗ |
| 2024-02-12 | Waters Kevin | Officer | S-Sale | D | Common Stock | 22,349 | 50.16 | 1.12M | 33,523 | — | ↗ |
| 2024-02-09 | Waters Kevin | Officer | S-Sale | D | Common Stock | 28,677 | 50.09 | 1.44M | 33,523 | — | ↗ |
| 2024-02-09 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 14,694 | 5.18 | 76.1K | 62,045 | — | ↗ |
| 2024-02-07 | Waters Kevin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 904 | 4.52 | 4.1K | 102,953 | — | ↗ |
| 2024-02-07 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 5,306 | 5.18 | 27.5K | 52,657 | — | ↗ |
| 2024-01-09 | Waters Kevin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 17,310 | 4.52 | 78.2K | 103,857 | — | ↗ |
| 2024-01-09 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 16,000 | 4.56 | 73.0K | 63,351 | — | ↗ |
| 2023-12-15 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 11,796 | 4.56 | 53.8K | 58,729 | — | ↗ |
| 2023-12-14 | Nouri Alaleh | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,204 | 4.56 | 14.6K | 41,493 | — | ↗ |
| 2023-12-13 | Waters Kevin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 71,465 | 4.52 | 323.0K | 121,167 | — | ↗ |
| 2023-12-08 | Waters Kevin | Officer | S-Sale | D | Common Stock | 6,888 | 40.02 | 275.6K | 33,523 | — | ↗ |
| 2023-12-07 | Waters Kevin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,837 | 4.52 | 17.3K | 199,520 | — | ↗ |
| 2023-12-06 | Waters Kevin | Officer | M-Exempt | A | Common Stock | 4,360 | 4.52 | 19.7K | 37,883 | — | ↗ |
| 2023-12-06 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 6,096 | 4.52 | 27.6K | 53,029 | — | ↗ |
| 2023-12-06 | MOLL FREDERIC H | Director | S-Sale | D | Common Stock | 27,242 | 39.25 | 1.07M | 808,233 | — | ↗ |
| 2023-11-13 | Wood Morgan Colby | Director | S-Sale | D | Common Stock | 25,000 | 32.19 | 804.8K | 112,425 | — | ↗ |
| 2023-10-18 | Zadno Reza | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,148 | 4.37 | 22.5K | 1,273,093 | — | ↗ |
| 2023-07-27 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 7,903 | 40.00 | 316.1K | 46,933 | — | ↗ |
| 2023-06-15 | Wood Morgan Colby | Director | A-Award | A | Common Stock | 2,711 | 0.00 | — | 137,425 | — | ↗ |
| 2023-06-15 | Waters Kevin | Officer | S-Sale | D | Common Stock | 22,631 | 35.12 | 794.9K | 33,523 | — | ↗ |
| 2023-06-15 | Sandoval Elisabeth | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | MOLL FREDERIC H | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | Krummel Thomas M | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | Harris Taylor C. | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | Garrett Mary | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | Dodrill Amy M. | Director | A-Award | A | Stock Option (Right to Buy) | 4,865 | 35.09 | 170.7K | 4,865 | — | ↗ |
| 2023-06-15 | Desai Antal Rohit | Director / 10% Owner | A-Award | A | Common Stock | 2,711 | 0.00 | — | 57,594 | — | ↗ |
| 2023-05-08 | Nouri Alaleh | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,123 | 4.52 | 54.8K | 65,452 | — | ↗ |
| 2023-04-28 | Zadno Reza | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 19,995 | 4.37 | 87.4K | 1,278,241 | — | ↗ |
| 2023-04-11 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 21,930 | 35.23 | 772.5K | 31,414 | — | ↗ |
| 2023-04-04 | Zadno Reza | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 20,022 | 4.37 | 87.5K | 1,298,236 | — | ↗ |
| 2023-03-16 | Zadno Reza | Director / Officer | S-Sale | D | Common Stock | 5,335 | 31.84 | 169.9K | 155,791 | — | ↗ |
| 2023-03-16 | Waters Kevin | Officer | S-Sale | D | Common Stock | 706 | 31.84 | 22.5K | 56,154 | — | ↗ |
| 2023-03-16 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 246 | 31.84 | 7.8K | 53,344 | — | ↗ |
| 2023-03-16 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 304 | 31.84 | 9.7K | 34,810 | — | ↗ |
| 2023-03-08 | Waters Kevin | Officer | S-Sale | D | Common Stock | 22,046 | 34.36 | 757.5K | 57,678 | — | ↗ |
| 2023-03-08 | Nouri Alaleh | Officer | M-Exempt | A | Common Stock | 10,000 | 4.52 | 45.2K | 35,114 | — | ↗ |
| 2023-03-07 | Waters Kevin | Officer | S-Sale | D | Common Stock | 7,136 | 34.15 | 243.7K | 79,724 | — | ↗ |
| 2023-03-03 | Wood Morgan Colby | Director | S-Sale | D | Common Stock | 12,203 | 35.94 | 438.6K | 137,511 | — | ↗ |
| 2023-02-16 | Zadno Reza | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 119,332 | 37.02 | 4.42M | 119,332 | — | ↗ |
| 2023-02-16 | Waters Kevin | Officer | A-Award | A | Stock Option (Right to Buy) | 47,732 | 37.02 | 1.77M | 47,732 | — | ↗ |
| 2023-02-16 | Shiblaq Hisham | Officer | A-Award | A | Stock Option (Right to Buy) | 47,732 | 37.02 | 1.77M | 47,732 | — | ↗ |
| 2023-02-16 | Nouri Alaleh | Officer | A-Award | A | Stock Option (Right to Buy) | 38,186 | 37.02 | 1.41M | 38,186 | — | ↗ |
| 2023-01-04 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 466 | 39.74 | 18.5K | 27,275 | — | ↗ |
| 2023-01-03 | Shiblaq Hisham | Officer | S-Sale | D | Common Stock | 9,736 | 39.76 | 387.1K | 39,468 | — | ↗ |
| 2022-12-27 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 1,476 | 41.36 | 61.0K | 5,650 | — | ↗ |
| 2022-12-19 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 11,489 | 43.08 | 494.9K | 7,126 | — | ↗ |
| 2022-12-16 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 20,000 | 41.97 | 839.3K | 27,126 | — | ↗ |
| 2022-12-05 | McGaughy R Kent Jr | Director | J-Other | D | Common Stock | 1,726,534 | 0.00 | — | 5,029,869 | — | ↗ |
| 2022-12-05 | Desai Antal Rohit | Director | J-Other | D | Common Stock | 1,726,534 | 0.00 | — | 5,029,869 | — | ↗ |
| 2022-11-14 | McGaughy R Kent Jr | Director | J-Other | D | Common Stock | 1,729,482 | 0.00 | — | 6,993,137 | — | ↗ |
| 2022-11-14 | Desai Antal Rohit | Director | J-Other | D | Common Stock | 1,729,482 | 0.00 | — | 6,993,137 | — | ↗ |
| 2022-09-09 | McGaughy R Kent Jr | 10% Owner | J-Other | D | Common Stock | 986,640 | 0.00 | — | 8,955,675 | — | ↗ |
| 2022-09-09 | Desai Antal Rohit | Director / 10% Owner | J-Other | D | Common Stock | 986,640 | 0.00 | — | 8,955,675 | — | ↗ |
| 2022-09-06 | White Tailed Ptarmigan, LP | Director | J-Other | D | Common Stock | 743,021 | 0.00 | — | 10,075,491 | — | ↗ |
| 2022-09-06 | McGaughy R Kent Jr | 10% Owner | J-Other | D | Common Stock | 743,021 | 0.00 | — | 10,075,491 | — | ↗ |
| 2022-09-06 | Desai Antal Rohit | Director | J-Other | D | Common Stock | 743,021 | 0.00 | — | 10,075,491 | — | ↗ |
| 2022-06-22 | Krummel Thomas M | Director | M-Exempt | A | Common Stock | 2,689 | 4.51 | 12.1K | 102,920 | — | ↗ |
| 2022-06-21 | Krummel Thomas M | Director | M-Exempt | D | Stock Option (Right to Buy) | 10,477 | 0.00 | — | 0 | — | ↗ |
| 2022-06-07 | Wood Morgan Colby | Director | A-Award | A | Common Stock | 4,205 | 0.00 | — | 4,205 | — | ↗ |
| 2022-06-07 | Sandoval Elisabeth | Director | A-Award | A | Common Stock | 4,205 | 0.00 | — | 4,205 | — | ↗ |
| 2022-06-07 | MOLL FREDERIC H | Director | A-Award | A | Common Stock | 4,205 | 0.00 | — | 4,205 | — | ↗ |
| 2022-06-07 | Krummel Thomas M | Director | A-Award | A | Common Stock | 4,205 | 38.85 | 163.4K | 8,410 | — | ↗ |
| 2022-06-07 | Harris Taylor C. | Director | A-Award | A | Common Stock | 4,205 | 38.85 | 163.4K | 4,205 | — | ↗ |
| 2022-06-07 | Garrett Mary | Director | A-Award | A | Common Stock | 2,001 | 37.48 | 75.0K | 8,760 | — | ↗ |
| 2022-06-07 | Dodrill Amy M. | Director | A-Award | A | Common Stock | 2,001 | 37.48 | 75.0K | 2,001 | — | ↗ |
| 2022-06-07 | Desai Antal Rohit | Director | A-Award | A | Common Stock | 4,205 | 0.00 | — | 4,205 | — | ↗ |
| 2022-05-16 | Nouri Alaleh | Officer | S-Sale | D | Common Stock | 678 | 35.06 | 23.8K | 46,468 | — | ↗ |
| 2022-03-31 | Zadno Reza | Officer | A-Award | A | Stock Option (Right to Buy) | 79,584 | 0.00 | — | 79,584 | — | ↗ |
| 2022-03-31 | Waters Kevin | Officer | A-Award | A | Common Stock | 7,914 | 29.38 | 232.5K | 60,545 | — | ↗ |
| 2022-03-31 | Shiblaq Hisham | Officer | A-Award | A | Stock Option (Right to Buy) | 7,924 | 34.99 | 277.3K | 7,924 | — | ↗ |
| 2022-03-31 | Nouri Alaleh | Officer | A-Award | A | Stock Option (Right to Buy) | 6,890 | 0.00 | — | 6,890 | — | ↗ |
| 2022-03-18 | Ott David C. | Director | S-Sale | D | Common Stock | 101,795 | 29.90 | 3.04M | 298,205 | — | ↗ |
| 2022-03-17 | White Tailed Ptarmigan, LP | Director | J-Other | D | Common Stock | 304,268 | 0.00 | — | 10,918,394 | — | ↗ |
| 2022-03-17 | Desai Antal Rohit | Director | J-Other | D | Common Stock | 304,268 | 0.00 | — | 10,918,394 | — | ↗ |
| 2022-03-17 | CPMG Inc | 10% Owner | J-Other | D | Common Stock | 304,268 | 0.00 | — | 10,918,394 | — | ↗ |
| 2022-03-11 | Wood Morgan Colby | Director | P-Purchase | A | Common Stock | 940 | 24.43 | 23.0K | 147,713 | — | ↗ |
| 2021-12-29 | Garrett Mary | Director | A-Award | A | Common Stock | 6,759 | 29.59 | 200.0K | 6,759 | — | ↗ |
| 2021-10-21 | Sandoval Elisabeth | Director | A-Award | A | Common Stock | 4,935 | 40.46 | 199.7K | 4,935 | — | ↗ |
| 2021-09-17 | Zadno Reza | Director / Officer | C-Conversion | D | Series F Convertible Preferred Stock | 3,394 | 0.00 | — | 0 | — | ↗ |
| 2021-09-17 | Wood Morgan Colby | Director | C-Conversion | D | Series B Convertible Preferred Stock | 34,230 | 0.00 | — | 0 | — | ↗ |
| 2021-09-17 | VIKING GLOBAL INVESTORS LP | 10% Owner | C-Conversion | A | Common Stock | 678,985 | 0.00 | — | 4,394,155 | — | ↗ |
| 2021-09-17 | MOLL FREDERIC H | Director | P-Purchase | A | Common Stock | 400,000 | 25.00 | 10.00M | 882,521 | — | ↗ |
| 2021-09-17 | Krummel Thomas M | Director | C-Conversion | A | Common Stock | 5,963 | 0.00 | — | 75,919 | — | ↗ |
| 2021-09-17 | Harris Taylor C. | Director | C-Conversion | A | Common Stock | 35,074 | 0.00 | — | 35,074 | — | ↗ |
| 2021-09-17 | Desai Antal Rohit | Director / 10% Owner | C-Conversion | D | Series E Convertible Preferred Stock | 3,038,934 | 0.00 | — | 0 | — | ↗ |
| 2021-09-17 | CPMG Inc | 10% Owner | P-Purchase | A | Common Stock | 440,000 | 25.00 | 11.00M | 11,222,662 | — | ↗ |
| 2021-09-14 | Zadno Reza | Director / Officer | — | D | Stock Option (Right to Buy) | 1,318,258 | 4.37 | 5.76M | 0 | — | ↗ |
| 2021-09-14 | Wood Morgan Colby | Director | — | D | Series B Convertible Preferred Stock | 34,230 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Waters Kevin | Officer | — | D | Stock Option (Right to Buy) | 70,219 | 5.18 | 363.6K | 0 | — | ↗ |
| 2021-09-14 | VIKING GLOBAL INVESTORS LP | 10% Owner | — | I | Series E Preferred Stock | 3,407,028 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Shiblaq Hisham | Officer | — | D | Stock Option (Right to Buy) | 31,578 | 5.18 | 163.5K | 0 | — | ↗ |
| 2021-09-14 | Nouri Alaleh | Officer | — | D | Stock Option (Right to Buy) | 57,894 | 7.27 | 420.7K | 0 | — | ↗ |
| 2021-09-14 | MOLL FREDERIC H | Director | — | D | Series D Convertible Preferred Stock | 108,214 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Krummel Thomas M | Director | — | D | Common Stock | 0 | 0.00 | — | 69,956 | — | ↗ |
| 2021-09-14 | Harris Taylor C. | Director | A-Award | A | Stock Option (Right to Buy) | 10,308 | 25.00 | 257.7K | 10,308 | — | ↗ |
| 2021-09-14 | Dodrill Amy M. | Director | — | D | Stock Option (Right to Buy) | 47,368 | 7.27 | 344.2K | 0 | — | ↗ |
| 2021-09-14 | Desai Antal Rohit | Director | — | I | Common Stock | 0 | 0.00 | — | 697,752 | — | ↗ |
| 2021-09-14 | CPMG Inc | 10% Owner | — | I | Series D Convertible Preferred Stock | 4,712,969 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-137.4K
Shares Outstanding
56.91M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Larry L. Wood, President & Chief Executive Officer | 304.8K | 1.70M | 7.22M | 7.23M | 243.9K | 91.3K | 16.78M | 86.06% | ↗ |
| 2 | 2025 | Reza Zadno, Ph.D., Former President & Chief Executive Officer | 471.3K | — | 3.79M | 1.29M | 472.0K | 743.2K | 6.77M | 75.07% | ↗ |
| 3 | 2025 | Kevin Waters, EVP, Chief Financial Officer | 502.3K | — | 1.48M | 503.6K | 256.1K | 7.5K | 2.75M | 72.15% | ↗ |
| 4 | 2025 | Alaleh Nouri, EVP, Chief Legal Officer & Corporate Secretary | 471.5K | — | 1.18M | 400.6K | 220.4K | 7.5K | 2.28M | 69.30% | ↗ |
| 5 | 2025 | Hisham Shiblaq Former EVP, Chief Commercial Officer | 336.0K | — | 1.01M | 343.4K | — | 275.8K | 1.96M | 68.86% | ↗ |
| 6 | 2024 | Reza Zadno, Ph.D., Former President & Chief Executive Officer | 671.9K | — | 4.07M | 1.14M | 639.7K | — | 6.52M | 79.89% | ↗ |
| 7 | 2024 | Reza Zadno, Ph.D., President & Chief Executive Officer | 671.9K | — | 4.07M | 1.14M | 639.7K | — | 6.52M | 79.89% | ↗ |
| 8 | 2024 | Hisham Shiblaq EVP, Chief Commercial Officer | 477.5K | — | 2.22M | 621.4K | 272.8K | — | 3.59M | 79.09% | ↗ |
| 9 | 2024 | Hisham Shiblaq Former EVP, Chief Commercial Officer | 477.5K | — | 2.22M | 621.4K | 272.8K | — | 3.59M | 79.09% | ↗ |
| 10 | 2024 | Alaleh Nouri, EVP, Chief Legal Officer & Corporate Secretary | 448.8K | — | 1.53M | 430.2K | 235.0K | 6.0K | 2.65M | 74.01% | ↗ |
| 11 | 2024 | Kevin Waters, EVP, Chief Financial Officer | 482.5K | — | 1.11M | 311.9K | 275.6K | 6.0K | 2.19M | 65.08% | ↗ |
| 12 | 2023 | Reza Zadno, Ph.D., Former President & Chief Executive Officer | 612.6K | — | 2.44M | 2.53M | 512.7K | — | 6.09M | 81.52% | ↗ |
| 13 | 2023 | Reza Zadno, Ph.D., President & Chief Executive Officer | 612.6K | — | 2.44M | 2.53M | 512.7K | — | 6.09M | 81.52% | ↗ |
| 14 | 2023 | Kevin Waters, EVP, Chief Financial Officer | 448.8K | — | 974.2K | 1.01M | 225.4K | 6.0K | 2.67M | 74.48% | ↗ |
| 15 | 2023 | Hisham Shiblaq Former EVP, Chief Commercial Officer | 430.0K | — | 974.2K | 1.01M | 216.0K | — | 2.63M | 75.45% | ↗ |
| 16 | 2023 | Hisham Shiblaq EVP, Chief Commercial Officer | 430.0K | — | 974.2K | 1.01M | 216.0K | — | 2.63M | 75.45% | ↗ |
| 17 | 2023 | Alaleh Nouri, EVP, Chief Legal Officer & Corporate Secretary | 410.8K | — | 779.3K | 808.8K | 189.1K | 6.0K | 2.19M | 72.39% | ↗ |
| 18 | 2022 | Reza Zadno, Ph.D., President & Chief Executive Officer | 575.0K | — | 1.38M | 1.50M | 684.0K | — | 4.13M | 69.53% | ↗ |
| 19 | 2022 | Kevin Waters, EVP, Chief Financial Officer | 415.0K | — | 276.9K | 301.3K | 329.1K | — | 1.32M | 43.73% | ↗ |
| 20 | 2022 | Hisham Shiblaq EVP, Chief Commercial Officer | 400.0K | 40.0K | 137.0K | 149.0K | 317.2K | — | 1.04M | 27.41% | ↗ |
| 21 | 2022 | Alaleh Nouri, EVP, Chief Legal Officer & Corporate Secretary | 398.0K | — | 119.1K | 129.5K | 315.6K | — | 962.2K | 25.84% | ↗ |
| 22 | 2021 | Reza Zadno, Ph.D., President & Chief Executive Officer | 490.0K | — | — | 615.2K | 269.5K | — | 1.37M | 44.75% | ↗ |
| 23 | 2021 | Kevin Waters, EVP, Chief Financial Officer | 388.1K | — | — | 309.2K | 155.3K | — | 852.6K | 36.26% | ↗ |
| 24 | 2021 | Hisham Shiblaq EVP, Chief Commercial Officer | 350.0K | — | — | 309.2K | 157.5K | — | 816.7K | 37.86% | ↗ |
| 25 | 2020 | Reza Zadno, Ph.D., President & Chief Executive Officer | 435.4K | — | — | 2.90M | 217.4K | — | 3.56M | 81.64% | ↗ |
| 26 | 2020 | Kevin Waters, EVP, Chief Financial Officer | 388.1K | 22.0K | — | 169.6K | 155.3K | — | 735.0K | 23.08% | ↗ |
| 27 | 2020 | Hisham Shiblaq EVP, Chief Commercial Officer | 310.5K | — | — | 131.8K | 139.7K | — | 582.0K | 22.64% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Larry L. Wood | President, Chief Executive Officer & Director | 2M | male |
| Kevin Waters | Executive Vice President & Chief Financial Officer | 765.9K | male |
| Alaleh Nouri | EVice President, Chief Legal Officer & Corporate Secretary | 699.4K | female |
| Christofer Christoforou | Executive Vice President of Operations | — | male |
| Bijesh Chandran | Executive Vice President of Regulatory Affairs & Quality Assurance | — | male |
| Barry Templin | Executive Vice President & Chief Technology Officer | — | male |
| Matthew James Bacso | Vice President of Investor Relations | — | male |
| Pooja Sharma Rao | Executive VP and Chief Strategy & Marketing Officer | — | female |
| Stacey L. Porter | Executive VP & Chief People Officer | — | female |
| Stephen J. McGill | Senior VP & GM of International | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PRCT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
